Patents by Inventor Robert G. Urban
Robert G. Urban has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20120201843Abstract: The present invention provides nucleic acids containing transcriptional units that encode CYP1B1 polypeptides or portions thereof, wherein the transcriptional units lack sequences found in the untranslated region (UTR) of naturally occurring forms of the CYP1B1 transcript. The nucleic acids of the invention lack translational repressor elements and thus provide for a system of enhanced translation of the CYP1B1 polypeptide or portions thereof. Also disclosed are methods of administering nucleic acids to a mammal and use in the treatment of proliferative disorders or cancer.Type: ApplicationFiled: March 19, 2012Publication date: August 9, 2012Applicant: Eisai, Inc.Inventors: Nazneen Aziz, Mary Lynne Hedley, Robert G. Urban, Andrew J. Tomlinson, Geoffrey Cole
-
Patent number: 8158594Abstract: The present invention provides nucleic acids containing transcriptional units that encode CYP1B1 polypeptides or portions thereof, wherein the transcriptional units lack sequences found in the untranslated region (UTR) of naturally occurring forms of the CYP1B1 transcript. The nucleic acids of the invention lack translational repressor elements and thus provide for a system of enhanced translation of the CYP1B1 polypeptide or portions thereof. Also disclosed are methods of administering nucleic acids to a mammal and use in the treatment of proliferative disorders or cancer.Type: GrantFiled: April 30, 2007Date of Patent: April 17, 2012Assignee: Eisai Inc.Inventors: Nazneen Aziz, Mary Lynne Hedley, Robert G. Urban, Andrew J. Tomlinson, Geoffrey Cole
-
Publication number: 20110158952Abstract: The invention includes methods of treating an HPV-mediated disease by administration to an individual of a pharmaceutical composition comprising a nucleic acid that encodes a polypeptide comprising an epitope of a naturally occurring HPV protein. The methods include the selection of individuals for treatment with the composition according to a the age of the recipient, as well as the use of the composition to elicit a cross-reactive anti-HPV immune response.Type: ApplicationFiled: June 7, 2010Publication date: June 30, 2011Applicant: EISAI INC.Inventors: Kathleen Beach, Mary Lynne Hedley, Robert G. Urban, Roman M. Chicz
-
Publication number: 20100233087Abstract: The present invention provides nucleic acids containing transcriptional units that encode CYP1B1 polypeptides or portions thereof, wherein the transcriptional units lack sequences found in the untranslated region (UTR) of naturally occurring forms of the CYP1B1 transcript. The nucleic acids of the invention lack translational repressor elements and thus provide for a system of enhanced translation of the CYP1B1 polypeptide or portions thereof. Also disclosed are methods of administering nucleic acids to a mammal and use in the treatment of proliferative disorders or cancer.Type: ApplicationFiled: April 30, 2007Publication date: September 16, 2010Applicant: MGI PHARMA BIOLOGICS, INC.Inventors: Nazneen Aziz, Mary Lynne Hedley, Robert G. Urban, Andrew J. Tomlinson, Geoffrey Cole
-
Patent number: 7241742Abstract: The present invention provides nucleic acids containing transcriptional units that encode CYP1B1 polypeptides or portions thereof, wherein the transcriptional units lack sequences found in the untranslated region (UTR) of naturally occurring forms of the CYP1B1 transcript. The nucleic acids of the invention lack translational repressor elements and thus provide for a system of enhanced translation of the CYP1B1 polypeptide or portions thereof. Also disclosed are methods of administering nucleic acids to a mammal and use in the treatment of proliferative disorders or cancer.Type: GrantFiled: October 31, 2001Date of Patent: July 10, 2007Assignee: MGI PHARMA Biologics, Inc.Inventors: Nazneen Aziz, Mary Lynne Hedley, Robert G. Urban, Andrew J. Tomlinson, Geoffrey Cole
-
Patent number: 7169603Abstract: The invention provides polypeptides containing ?-MSH that can be used to treat diseases characterized by inflammation and/or autoimmunity. Also included in the invention are ?-MSH analogs and nucleic acids encoding polypeptides containing ?-MSH and ?-MSH analogs optionally linked to heterologous sequences. Also included in the invention are methods of delivering ?-MSH containing peptides, ?-MSH analogs, an DNA encoding ?-MSH and ?-MSH analogs.Type: GrantFiled: July 16, 2001Date of Patent: January 30, 2007Assignee: MGI Pharma Biologics, Inc.Inventors: Mary Lynne Hedley, Robert G. Urban, Nazneen Aziz, Hongmin Chen, Bijan Etemad-Moghadam, Peng Yin
-
Patent number: 7097843Abstract: The invention provides immunogenic peptides from the HPV type 16 E7 protein that comprise overlapping class I restricted T cell epitopes. Also disclosed are methods of administering DNA molecules encoding these peptides to a host mammal.Type: GrantFiled: June 24, 2003Date of Patent: August 29, 2006Assignee: MGI Pharma Biologics, Inc.Inventors: Robert G. Urban, Roman M. Chicz, Edward J. Collins, Mary Lynne Hedley
-
Publication number: 20040236091Abstract: Polypeptides representative of proteins expressed by a given cell type and isolated nucleic acids that encode the polypeptides are disclosed. The compositions and method described can be used to define a cell type at a given developmental, metabolic, or disease stage by identifying and cataloging proteins expressed in the cell. The compositions can also be used in the manufacture of therapeutics as well as in diagnostics and drug screening.Type: ApplicationFiled: June 17, 2004Publication date: November 25, 2004Inventors: Roman M. Chicz, Andrew J. Tomlinson, Robert G. Urban
-
Publication number: 20040229809Abstract: The invention provides immunogenic peptides from the HPV type 16 E7 protein that comprise overlapping class I restricted T cell epitopes. Also disclosed are methods of administering DNA molecules encoding these peptides to a host mammal.Type: ApplicationFiled: June 24, 2003Publication date: November 18, 2004Applicant: Zycos Inc., a Delaware corporationInventors: Robert G. Urban, Roman M. Chicz, Edward J. Collins, Mary Lynne Hedley
-
Publication number: 20040224338Abstract: An expressed protein tag (EPT) profile characteristic for a given cell, the profile including a representation of at least ten different polypeptides expressed by the cell and bound by a given type of multi-ligand binding receptor; and computer-assisted manipulation of such a profile.Type: ApplicationFiled: March 24, 2004Publication date: November 11, 2004Applicant: Zycos Inc., a Delaware corporationInventors: Roman M. Chicz, Mary Lynne Hedley, Charles Hsu, Robert G. Urban
-
Patent number: 6582704Abstract: The invention provides immunogenic peptides from the HPV type 16 E7 protein that comprise overlapping class I restricted T cell epitopes. Also disclosed are methods of administering DNA molecules encoding these peptides to a host mammal.Type: GrantFiled: January 12, 2001Date of Patent: June 24, 2003Assignee: Zycos Inc.Inventors: Robert G. Urban, Roman M. Chicz, Edward J. Collins, Mary Lynne Hedley
-
Publication number: 20030028000Abstract: The present invention provides nucleic acids containing transcriptional units that encode CYP1B1 polypeptides or portions thereof, wherein the transcriptional units lack sequences found in the untranslated region (UTR) of naturally occurring forms of the CYP1B1 transcript. The nucleic acids of the invention lack translational repressor elements and thus provide for a system of enhanced translation of the CYP1B1 polypeptide or portions thereof. Also disclosed are methods of administering nucleic acids to a mammal and use in the treatment of proliferative disorders or cancer.Type: ApplicationFiled: October 31, 2001Publication date: February 6, 2003Inventors: Nazneen Aziz, Mary Lynne Hedley, Robert G. Urban, Andrew J. Tomlinson, Geoffrey Cole
-
Publication number: 20010006639Abstract: The invention provides immunogenic peptides from the HPV type 16 E7 protein that comprise overlapping class I restricted T cell epitopes. Also disclosed are methods of administering DNA molecules encoding these peptides to a host mammal.Type: ApplicationFiled: January 12, 2001Publication date: July 5, 2001Applicant: Zycos, Inc., Delaware corporationInventors: Robert G. Urban, Roman M. Chiez, Edward J. Collins, Mary Lynne Hedley
-
Patent number: 6183746Abstract: The invention provides immunogenic peptides from the HPV type 16 E7 protein that comprise overlapping class I restricted T cell epitopes. Also disclosed are methods of administering DNA molecules encoding these peptides to a host mammal.Type: GrantFiled: October 9, 1998Date of Patent: February 6, 2001Assignee: Zycos Inc.Inventors: Robert G. Urban, Roman M. Chicz, Edward J. Collins, Mary Lynne Hedley
-
Patent number: 6013258Abstract: The invention provides immunogenic peptides from the HPV type 16 E7 protein that comprise overlapping class I restricted T cell epitopes. Also disclosed are methods of administering DNA molecules encoding these peptides to a host mammal.Type: GrantFiled: October 9, 1997Date of Patent: January 11, 2000Assignee: Zycos Inc.Inventors: Robert G. Urban, Roman M. Chicz, Edward J. Collins, Mary Lynne Hedley
-
Patent number: 4534002Abstract: A method and apparatus is disclosed for substantially minimizing or eliminating scrap lenghts of material from being cut from an initial undeterminable length of material. A material is fed toward a cutting device. The material is cut in accordance with an initial cut length schedule that is a value between acceptable customer's limits. The trailing end of the material is monitored and the length of the remaining material is determined. The cut length schedule is then adjusted within the limits in accordance with the determined remaining length to bring the last length of material within the permissible limits or if not possible, then to substantially minimize the scrap cut length of material which falls outside of the limits.Type: GrantFiled: January 19, 1983Date of Patent: August 6, 1985Assignee: Republic Steel CorporationInventor: Robert G. Urban